Dr. Hyla Cass M.D and Dr. Dr. Susanne Bennett are oncology clinicians at the Santa Monica Health and Medical Center in California, USA. They have experience in the clinical use of MCP on the treatment of patients with advanced cancer for more than 10 years.

We met them at the Anaheim Natural Products EXPO WEST (Engredea) on March 10 this year, and had an in-depth exchange of experiences in clinical application of MCP. According to Dr. Hyla Cass MD, based on her more than 10 years of clinical experience, MCP has been shown to have significant inhibitory effects on lung cancer, colon cancer, gastric cancer, breast cancer and other tumors, especially during the adjuvant chemotherapy period. MCP has significantly function on improve the quality of life on tumor patients. Our staff gave them a detailed introduction of the technical parameters of our newly developed high-purity MCP.

After tasted our new grade MCP on the booth, they were full of praise for the taste, water solubility and purity of our MCP. Through careful comparison and analysis of the technical parameters and physical properties between our MCP and other MCP products in the US, they highly agree that our high-purity MCP products are better in many aspects including taste, solution transparency, purity, molecular weight distribution , etc.

 Upon leaving, the two doctors asked for some samples for testing, and repeatedly expressed their expectation to cooperate as soon as possible.